Profilo
Yutaka Hashimoto worked as an Executive Director at C&O Pharmaceutical Technology (Holdings) Ltd.
and as a Senior Manager-Overseas Business Division at Shionogi & Co., Ltd.
He holds an MBA from Kobe University and an undergraduate degree from Tohoku University.
Precedenti posizioni note di Yutaka Hashimoto
Società | Posizione | Fine |
---|---|---|
SHIONOGI & CO., LTD. | Corporate Officer/Principal | - |
C&O Pharmaceutical Technology (Holdings) Ltd.
C&O Pharmaceutical Technology (Holdings) Ltd. Pharmaceuticals: MajorHealth Technology C&O Pharmaceutical Technology (Holdings) Ltd. manufactures and distributes pharmaceutical products. It offers anti-infection and gastrointestinal drugs, drugs for ageing adults, and specialized drugs. The firm's products are used for various indications, such as skin soft tissues infections, analgesic and antipyretic, indigestion or gastro esophageal reflux disorder, respiratory tract infections, sinusitis, hypertension and migraine. The company was founded by Lai Chi Ma and Bin Gao in 2003 and is headquartered in Hong Kong. | Direttore/Membro del Consiglio | - |
Formazione di Yutaka Hashimoto
Tohoku University | Undergraduate Degree |
Kobe University | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
SHIONOGI & CO., LTD. | Health Technology |
Aziende private | 1 |
---|---|
C&O Pharmaceutical Technology (Holdings) Ltd.
C&O Pharmaceutical Technology (Holdings) Ltd. Pharmaceuticals: MajorHealth Technology C&O Pharmaceutical Technology (Holdings) Ltd. manufactures and distributes pharmaceutical products. It offers anti-infection and gastrointestinal drugs, drugs for ageing adults, and specialized drugs. The firm's products are used for various indications, such as skin soft tissues infections, analgesic and antipyretic, indigestion or gastro esophageal reflux disorder, respiratory tract infections, sinusitis, hypertension and migraine. The company was founded by Lai Chi Ma and Bin Gao in 2003 and is headquartered in Hong Kong. | Health Technology |
- Borsa valori
- Insiders
- Yutaka Hashimoto